IR Biosciences Holdings Inc.
IRBS · OTC
12/31/2010 | 9/30/2010 | 6/30/2010 | 3/31/2010 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $3 | $7 | $6 |
| Enterprise Value | $4 | $3 | $7 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$3 | $2 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$3 | $1 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.02 | -0.17 | 0.08 | -0.24 |
| % Growth | 88% | -312.5% | 133.3% | – |
| Operating Cash Flow | -$0 | $0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | $0 | -$0 |